SynthesisOncology research2025

Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review.

Giacomo Iovane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.